Mohammad Rostamzadeh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mohammad Rostamzadeh has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Amir Heidari
Department of Cardiology, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 shared publications - Reza Faramarzzadeh
Department of Cardiology, Seyed-al-shohada Cardiology Hospital, Urmia University of Medical Science, Urmia, Iran
4 shared publications - Abdolmohammad Ranjbar
Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
2 shared publications - Roozbeh Roohinezhad
Department of Urology, Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran
2 shared publications - Akram Shariati
Department of Cardiology, School of Medicine, Urmia University of Medical Sciences, Urmia, Iran
1 shared publication - Ali Emadzadeh
Department of Internal Medicine, MMS.C., Islamic Azad University, Mashhad, Iran
1 shared publication
Latest Publications
- Open Access
- 28 March 2026
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
- Vol. 15 (3) , e28709
Relationship between neutrophil percentage to albumin ratio and cardiovascular disease mortality in chronic kidney disease patients; a systematic review and meta-analysis
Introduction: Chronic inflammation plays a significant role in cardiovascular disease (CVD)–related mortality among patients with chronic kidney disease (CKD). The neutrophil‑to‑albumin percentage ratio (NPAR) has emerged as an indicator of an individual’s inflammatory status. This study aimed to investigate the association between elevated NPAR and the risk of CVD mortality in patients with CKD. Materials and Methods: The study was conducted in accordance with the PRISMA reporting guidelines. Comprehensive searches were performed across the Cochrane Library, Scopus, Web of Science, Embase, and PubMed databases, as well as the Google Scholar search engine, up to 30 January 2026. All statistical analyses were carried out using STATA version 14. Results: Compared with lower NPAR values, elevated NPAR was associated with a higher risk of cardiovascular mortality (OR = 1.54; 95% CI: 1.33–1.78) and all‑cause mortality (OR = 1.62; 95% CI: 1.40–1.89) in patients with CKD. In addition, higher NPAR increased the risk of CVD‑related death among patients undergoing hemodialysis (OR = 1.66; 95% CI: 1.29–2.15) and peritoneal dialysis (OR = 1.56; 95% CI: 1.25–1.94). Furthermore, the third quartile of NPAR (OR = 1.44; 95% CI: 1.16–1.78), the fourth quartile (OR = 1.92; 95% CI: 1.61–2.30), the second tertile (OR = 1.38; 95% CI: 1.07–1.80), and the third tertile (OR = 1.97; 95% CI: 1.61–2.41) were all associated with increased CVD mortality compared with the lowest category. Elevated NPAR also increased the risk of CVD‑related mortality in both men (OR = 1.23; 95% CI: 1.04–1.45) and women (OR = 1.16; 95% CI: 1.08–1.24) with CKD. Conclusion: Higher NPAR levels were associated with an increased likelihood of cardiovascular and all‑cause mortality among individuals with CKD. As NPAR values rose, the risk of CVD‑related death increased correspondingly when compared with lower levels. In addition, cardiovascular mortality risk was greater in men than in women, and higher among patients receiving hemodialysis than those undergoing peritoneal dialysis. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (ID: CRD420261304086) and Research Registry (UIN: reviewregistry2082) websites.
- 28 March 2026
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
- Vol. 15 (3) , e28709
Open AccessRelationship between neutrophil percentage to albumin ratio and cardiovascular disease mortality in chronic kidney disease patients; a systematic review and meta-analysis
Introduction: Chronic inflammation plays a significant role in cardiovascular disease (CVD)–related mortality among patients with chronic kidney disease (CKD). The neutrophil‑to‑albumin percentage ratio (NPAR) has emerged as an indicator of an individual’s inflammatory status. This study aimed to investigate the association between elevated NPAR and the risk of CVD mortality in patients with CKD. Materials and Methods: The study was conducted in accordance with the PRISMA reporting guidelines. Comprehensive searches were performed across the Cochrane Library, Scopus, Web of Science, Embase, and PubMed databases, as well as the Google Scholar search engine, up to 30 January 2026. All statistical analyses were carried out using STATA version 14. Results: Compared with lower NPAR values, elevated NPAR was associated with a higher risk of cardiovascular mortality (OR = 1.54; 95% CI: 1.33–1.78) and all‑cause mortality (OR = 1.62; 95% CI: 1.40–1.89) in patients with CKD. In addition, higher NPAR increased the risk of CVD‑related death among patients undergoing hemodialysis (OR = 1.66; 95% CI: 1.29–2.15) and peritoneal dialysis (OR = 1.56; 95% CI: 1.25–1.94). Furthermore, the third quartile of NPAR (OR = 1.44; 95% CI: 1.16–1.78), the fourth quartile (OR = 1.92; 95% CI: 1.61–2.30), the second tertile (OR = 1.38; 95% CI: 1.07–1.80), and the third tertile (OR = 1.97; 95% CI: 1.61–2.41) were all associated with increased CVD mortality compared with the lowest category. Elevated NPAR also increased the risk of CVD‑related mortality in both men (OR = 1.23; 95% CI: 1.04–1.45) and women (OR = 1.16; 95% CI: 1.08–1.24) with CKD. Conclusion: Higher NPAR levels were associated with an increased likelihood of cardiovascular and all‑cause mortality among individuals with CKD. As NPAR values rose, the risk of CVD‑related death increased correspondingly when compared with lower levels. In addition, cardiovascular mortality risk was greater in men than in women, and higher among patients receiving hemodialysis than those undergoing peritoneal dialysis. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (ID: CRD420261304086) and Research Registry (UIN: reviewregistry2082) websites.
- 1 January 2026
- Published by Maad Rayan Publishing Company in Journal of Parathyroid Disease
- Vol. 14 (1) , e13317
Cross-talk of bone remodeling and cardiac dysfunction; reimagining the bone-heart axis in atherosclerosis pathogenesis
Recent findings detected a dynamic, reciprocal relationship between bone remodeling and cardiac dysfunction, significantly influencing atherosclerosis pathogenesis. The bone-heart axis consists of bidirectional signaling of bone-derived factors and dysregulated mineral metabolism, which directly affect vascular calcification, endothelial function, and myocardial stress. Conversely, cardiac hormones and systemic inflammation modulate osteoclast/osteoblast activity. Critically, shared molecular pathways, like RANKL/RANK/OPG modulate both skeletal turnover and vascular inflammation/calcification. Pathological bone resorption releases calcium and matrix vesicles that nucleate vascular calcification, accelerating atherosclerotic plaque instability. Reimagining this axis emphasizes on osteo-immunological mechanisms with central role in cardiovascular disease progression, suggesting integrated therapeutic targets for atherosclerosis beyond traditional lipid-centric approaches.
- 1 January 2026
- Published by Maad Rayan Publishing Company in Journal of Parathyroid Disease
- Vol. 14 (1) , e13317
Cross-talk of bone remodeling and cardiac dysfunction; reimagining the bone-heart axis in atherosclerosis pathogenesis
Recent findings detected a dynamic, reciprocal relationship between bone remodeling and cardiac dysfunction, significantly influencing atherosclerosis pathogenesis. The bone-heart axis consists of bidirectional signaling of bone-derived factors and dysregulated mineral metabolism, which directly affect vascular calcification, endothelial function, and myocardial stress. Conversely, cardiac hormones and systemic inflammation modulate osteoclast/osteoblast activity. Critically, shared molecular pathways, like RANKL/RANK/OPG modulate both skeletal turnover and vascular inflammation/calcification. Pathological bone resorption releases calcium and matrix vesicles that nucleate vascular calcification, accelerating atherosclerotic plaque instability. Reimagining this axis emphasizes on osteo-immunological mechanisms with central role in cardiovascular disease progression, suggesting integrated therapeutic targets for atherosclerosis beyond traditional lipid-centric approaches.
- Open Access
- 14 September 2025
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
- Vol. 15 (1) , e27655
Association of life’s essential 8 as a Cardiovascular Health Index with risk of chronic kidney disease; a systematic review and meta-analysis
Introduction: Due to the close association between chronic kidney disease (CKD) and cardiovascular disease (CVD), maintaining optimal cardiovascular health (CVH) may serve as a preventive strategy to reduce the risk of CKD and its related health burden. Therefore, this study aimed to investigate the association between Life’s Essential 8 (LE8) and the risk of CKD. Materials and Methods: This study systematically searched the Cochrane, Embase, PubMed, ProQuest, Web of Science, Scopus, and Google Scholar databases up to April 26, 2025. Data analysis was performed using IBM SPSS Statistics version 19 and STATA version 14. Results: An increase in the LE8 score was associated with a reduced risk of CKD, as indicated by the odds ratio (OR: 0.74, 95% CI: 0.67–0.82) and hazard ratio (HR: 0.60, 95% CI: 0.46–0.77). The protective effect of higher LE8 scores was observed across various subgroups: individuals aged 40–49 (OR: 0.81, 95% CI: 0.78–0.84), 50–59 (OR: 0.75, 95% CI: 0.60–0.94), males (OR: 0.81, 95% CI: 0.76–0.87), females (OR: 0.91, 95% CI: 0.87–0.95), and populations from the UK (OR: 0.60, 95% CI: 0.46–0.77), China (OR: 0.64, 95% CI: 0.63–0.65), and the USA (OR: 0.77, 95% CI: 0.72–0.81). Similarly, both cohort studies (OR: 0.66, 95% CI: 0.54–0.81) and cross-sectional studies (OR: 0.73, 95% CI: 0.66–0.81) confirmed this inverse association. Moreover, compared to low LE8 scores, moderate (OR: 0.58, 95% CI: 0.52–0.65) and high (OR: 0.43, 95% CI: 0.35–0.53) LE8 scores were significantly associated with reduced CKD risk. Conclusion: An increase in the LE8 score was associated with a greater reduction in the risk of CKD in older age groups compared to younger ones, and in men compared to women. Moreover, the higher the LE8 score, the lower the risk of developing CKD. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (ID: CRD420251043587) and Research Registry (UIN: reviewregistry2006) websites.
- 14 September 2025
- Published by Maad Rayan Publishing Company in Journal of Nephropathology
- Vol. 15 (1) , e27655
Open AccessAssociation of life’s essential 8 as a Cardiovascular Health Index with risk of chronic kidney disease; a systematic review and meta-analysis
Introduction: Due to the close association between chronic kidney disease (CKD) and cardiovascular disease (CVD), maintaining optimal cardiovascular health (CVH) may serve as a preventive strategy to reduce the risk of CKD and its related health burden. Therefore, this study aimed to investigate the association between Life’s Essential 8 (LE8) and the risk of CKD. Materials and Methods: This study systematically searched the Cochrane, Embase, PubMed, ProQuest, Web of Science, Scopus, and Google Scholar databases up to April 26, 2025. Data analysis was performed using IBM SPSS Statistics version 19 and STATA version 14. Results: An increase in the LE8 score was associated with a reduced risk of CKD, as indicated by the odds ratio (OR: 0.74, 95% CI: 0.67–0.82) and hazard ratio (HR: 0.60, 95% CI: 0.46–0.77). The protective effect of higher LE8 scores was observed across various subgroups: individuals aged 40–49 (OR: 0.81, 95% CI: 0.78–0.84), 50–59 (OR: 0.75, 95% CI: 0.60–0.94), males (OR: 0.81, 95% CI: 0.76–0.87), females (OR: 0.91, 95% CI: 0.87–0.95), and populations from the UK (OR: 0.60, 95% CI: 0.46–0.77), China (OR: 0.64, 95% CI: 0.63–0.65), and the USA (OR: 0.77, 95% CI: 0.72–0.81). Similarly, both cohort studies (OR: 0.66, 95% CI: 0.54–0.81) and cross-sectional studies (OR: 0.73, 95% CI: 0.66–0.81) confirmed this inverse association. Moreover, compared to low LE8 scores, moderate (OR: 0.58, 95% CI: 0.52–0.65) and high (OR: 0.43, 95% CI: 0.35–0.53) LE8 scores were significantly associated with reduced CKD risk. Conclusion: An increase in the LE8 score was associated with a greater reduction in the risk of CKD in older age groups compared to younger ones, and in men compared to women. Moreover, the higher the LE8 score, the lower the risk of developing CKD. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (ID: CRD420251043587) and Research Registry (UIN: reviewregistry2006) websites.
- Open Access
- 1 July 2025
- Published by National Academy of Sciences of Tajikistan in Nursing and Midwifery Journal
- Vol. 23 (2) , 17-25
The Effect of Self-Care Education on the Quality of Life and Readmission of Patients with Heart Failure: A Quasi-Experimental Study
Background Heart failure is one of the most common chronic diseases and cardiac disorders, as well as a leading cause of death in adults. Therefore, patients with heart failure can improve their comfort, functional abilities, and disease management by acquiring training in self-care skills. This study aimed to determine the effect ...
- 1 July 2025
- Published by National Academy of Sciences of Tajikistan in Nursing and Midwifery Journal
- Vol. 23 (2) , 17-25
Open AccessThe Effect of Self-Care Education on the Quality of Life and Readmission of Patients with Heart Failure: A Quasi-Experimental Study
Background Heart failure is one of the most common chronic diseases and cardiac disorders, as well as a leading cause of death in adults. Therefore, patients with heart failure can improve their comfort, functional abilities, and disease management by acquiring training in self-care skills. This study aimed to determine the effect ...
- Open Access
- 28 December 2024
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 14 (1) , e12755
Relationship between systemic immune-inflammation Index and contrast-induced acute kidney injury in cardiovascular patients: systematic review and meta-analysis
Introduction: Contrast-induced acute kidney injury (CI-AKI) imposes high costs and various complications on individuals and society. Considering that inflammation is a significant risk factor for CI-AKI incidence, the present research aimed to investigate the relationship between the systematic immune-inflammation (SII) index and the CI-AKI risk in cardiovascular patients using the systematic review and meta-analysis method. Materials and Methods: In the present study, ProQuest, PubMed, Embase, Web of Science, Cochrane, Scopus, and Google Scholar databases were used to search for articles published until October 16, 2024. Data analysis was conducted using the STATA 14 software, and tests with P values < 0.05 were considered statistically significant. Results: There was no significant association between the SII index and risk of CI-AKI in patients who underwent carotid artery angiography (OR: 1; 95% CI: 1, 1.01) or coronary angiography (OR: 1.96; 95% CI: 0.94, 4.11). However, in patients undergoing percutaneous coronary intervention (PCI) (OR: 1.01; 95% CI: 1, 1.02), high SII index levels increased the risk of CI-AKI. High SII index levels (OR: 1.01; 95% CI: 1.01, 1.02), higher ages (OR: 1.04; 95% CI: 1.02, 1.06), high-sensitivity C-reactive protein (hs-CRP) (OR: 1.01; 95% CI: 1, 1.02), hypertension (OR: 1.63; 95% CI: 1.31, 2.03), diabetes mellitus (OR: 1.73; 95% CI: 1.12, 2.68), neutrophil to lymphocyte ratio (NLR) (OR: 1.09; 95% CI: 1.01, 1.17), and neutrophil count (OR: 1.12; 95% CI: 1.08, 1.16) increased the risk of CI-AKI in cardiovascular patients. On the other hand, estimated glomerular filtration rate (eGFR) (OR: 0.98; 95% CI: 0.98, 0.99), lymphocyte count (OR: 0.47; 95% CI: 0.31, 0.71), and hemoglobin (OR: 0.97; 95% CI: 0.96, 0.98), albumin (OR: 0.96; 95% CI: 0.93, 0.99) in individuals with CIN were lower than those in the no-CIN group. Conclusion: High systemic immune-inflammation index levels, age, NLR, hs-CRP, hypertension, diabetes mellitus, and neutrophil count were among the risk factors of CI-AKI incidence in cardiovascular patients. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (ID: CRD42024604243) and Research Registry (UIN: reviewregistry1904) website.
- 28 December 2024
- Published by Maad Rayan Publishing Company in Journal of Nephropharmacology
- Vol. 14 (1) , e12755
Open AccessRelationship between systemic immune-inflammation Index and contrast-induced acute kidney injury in cardiovascular patients: systematic review and meta-analysis
Introduction: Contrast-induced acute kidney injury (CI-AKI) imposes high costs and various complications on individuals and society. Considering that inflammation is a significant risk factor for CI-AKI incidence, the present research aimed to investigate the relationship between the systematic immune-inflammation (SII) index and the CI-AKI risk in cardiovascular patients using the systematic review and meta-analysis method. Materials and Methods: In the present study, ProQuest, PubMed, Embase, Web of Science, Cochrane, Scopus, and Google Scholar databases were used to search for articles published until October 16, 2024. Data analysis was conducted using the STATA 14 software, and tests with P values < 0.05 were considered statistically significant. Results: There was no significant association between the SII index and risk of CI-AKI in patients who underwent carotid artery angiography (OR: 1; 95% CI: 1, 1.01) or coronary angiography (OR: 1.96; 95% CI: 0.94, 4.11). However, in patients undergoing percutaneous coronary intervention (PCI) (OR: 1.01; 95% CI: 1, 1.02), high SII index levels increased the risk of CI-AKI. High SII index levels (OR: 1.01; 95% CI: 1.01, 1.02), higher ages (OR: 1.04; 95% CI: 1.02, 1.06), high-sensitivity C-reactive protein (hs-CRP) (OR: 1.01; 95% CI: 1, 1.02), hypertension (OR: 1.63; 95% CI: 1.31, 2.03), diabetes mellitus (OR: 1.73; 95% CI: 1.12, 2.68), neutrophil to lymphocyte ratio (NLR) (OR: 1.09; 95% CI: 1.01, 1.17), and neutrophil count (OR: 1.12; 95% CI: 1.08, 1.16) increased the risk of CI-AKI in cardiovascular patients. On the other hand, estimated glomerular filtration rate (eGFR) (OR: 0.98; 95% CI: 0.98, 0.99), lymphocyte count (OR: 0.47; 95% CI: 0.31, 0.71), and hemoglobin (OR: 0.97; 95% CI: 0.96, 0.98), albumin (OR: 0.96; 95% CI: 0.93, 0.99) in individuals with CIN were lower than those in the no-CIN group. Conclusion: High systemic immune-inflammation index levels, age, NLR, hs-CRP, hypertension, diabetes mellitus, and neutrophil count were among the risk factors of CI-AKI incidence in cardiovascular patients. Registration: This study has been compiled based on the PRISMA checklist, and its protocol was registered on the PROSPERO (ID: CRD42024604243) and Research Registry (UIN: reviewregistry1904) website.